0001144204-17-041368 Sample Contracts

ARRAY BIOPHARMA INC. FIRST AMENDMENT TO SUBORDINATED CONVERTIBLE PROMISSORY NOTES
Subordinated Convertible Promissory Notes • August 9th, 2017 • Array Biopharma Inc • Pharmaceutical preparations

This First Amendment to Subordinated Convertible Promissory Notes (this “Amendment”) is entered into as of August 7, 2017 by and among Array BioPharma Inc., a Delaware corporation (the “Company”), Redmile Biopharma Investments I, L.P. (“Biopharma I”) and Redmile Capital Offshore Fund II, Ltd. (“Offshore II”, together with Biopharma I, the “Noteholders”).

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!